Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
1.850
+0.060 (3.35%)
Dec 20, 2024, 4:00 PM EST - Market closed

Company Description

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.

The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.

In addition, it offers post-contract customer support, installation, training, and other professional services.

The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally.

Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Accuray Incorporated
Accuray logo
Country United States
Founded 1990
IPO Date Feb 8, 2007
Industry Medical Devices
Sector Healthcare
Employees 987
CEO Suzanne Winter

Contact Details

Address:
1240 Deming Way
Madison, Wisconsin 53717-1954
United States
Phone 608 824 2800
Website accuray.com

Stock Details

Ticker Symbol ARAY
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0001138723
CUSIP Number 004397105
ISIN Number US0043971052
Employer ID 20-8370041
SIC Code 3841

Key Executives

Name Position
Suzanne Winter M.B.A. President, Chief Executive Officer and Director
Ali Pervaiz Senior Vice President and Chief Financial Officer
Michael Hoge Senior Vice President of Global Operations
Jesse Chew J.D. Senior Vice President, Chief Legal Officer and Company Secretary
Sandeep Chalke Senior Vice President and Chief Commercial Officer
Michael J. Murphy CPA Principal accounting officer
John M. Dunn Senior Vice President, Chief Information and Security Officer
Beth Kaplan Public Relations Director
Melanie Rivers Senior Vice President, Chief Human Resources Officer
Jim Dennison Senior Vice President and Chief Quality and Development Officer

Latest SEC Filings

Date Type Title
Dec 11, 2024 8-K Current Report
Nov 26, 2024 S-8 Securities to be offered to employees in employee benefit plans
Nov 25, 2024 8-K Current Report
Nov 6, 2024 10-Q Quarterly Report
Nov 6, 2024 8-K Current Report
Oct 21, 2024 8-K Current Report
Oct 15, 2024 8-K Current Report
Oct 4, 2024 ARS Filing
Oct 4, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 4, 2024 DEF 14A Other definitive proxy statements